Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in ADPKD with severe renal insufficiency
NCT01223755Phase 3Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Sep 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Mario Negri Institute for Pharmacological Research. Started Sep 2010; status: terminated.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT01223755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01223755.